Click for best price
AntiPeptic Ulcer Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 8965.2 million
|
Forecast Market size by 2029 |
US$ 20860 million
|
| Growth Rate |
CAGR of 12.8% |
Number of Pages |
69 Pages |
Anti-peptic Ulcre drug is one of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
This report aims to provide a comprehensive presentation of the global market for Anti-Peptic Ulcer Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Peptic Ulcer Drugs. This report contains market size and forecasts of Anti-Peptic Ulcer Drugs in global, including the following market information:
Global Anti-Peptic Ulcer Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Peptic Ulcer Drugs market was valued at US$ 8965.2 million in 2022 and is projected to reach US$ 20860 million by 2029, at a CAGR of 12.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Anti-Peptic Ulcer Drugs key players include AstraZeneca, Ask-pharm, Takeda, Yangtze River Pharm, Shandong Luoxin, etc. Global top five players hold a share about 50%.
In terms of product, the segment includes Proton Pump Inhibitors (PPIs), Potassium-Competitive Acid Blockers (P-CAB), Antacids, H2 Antagonists, Ulcer Protective Drugs. And in terms of application, the application includes Gastritis, Gastric Ulcers, Duodenal Ulcers, Gastroesophageal Reflux Disease (GERD).
We surveyed the Anti-Peptic Ulcer Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Peptic Ulcer Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Type, 2022 (%)
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Ulcer Protective Drugs
Global Anti-Peptic Ulcer Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, by Application, 2022 (%)
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Global Anti-Peptic Ulcer Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-Peptic Ulcer Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Peptic Ulcer Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Peptic Ulcer Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Ask-pharm
Takeda
Yangtze River Pharm
Shandong Luoxin
Huadong Medicine
Changzhou Siyao
Beijing Yuekang
Guangdong Dahua
Xian Janssen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Peptic Ulcer Drugs, market overview.
Chapter 2: Global Anti-Peptic Ulcer Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-Peptic Ulcer Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Peptic Ulcer Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Peptic Ulcer Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 8965.2 million
|
| Forecast Market size by 2029 |
US$ 20860 million
|
| Growth Rate |
CAGR of 12.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Peptic Ulcer Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Peptic Ulcer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Peptic Ulcer Drugs Overall Market Size
2.1 Global Anti-Peptic Ulcer Drugs Market Size: 2022 VS 2029
2.2 Global Anti-Peptic Ulcer Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Peptic Ulcer Drugs Players in Global Market
3.2 Top Global Anti-Peptic Ulcer Drugs Companies Ranked by Revenue
3.3 Global Anti-Peptic Ulcer Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-Peptic Ulcer Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-Peptic Ulcer Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-Peptic Ulcer Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Peptic Ulcer Drugs Market Size Markets, 2022 & 2029
4.1.2 Proton Pump Inhibitors (PPIs)
4.1.3 Potassium-Competitive Acid Blockers (P-CAB)
4.1.4 Antacids
4.1.5 H2 Antagonists
4.1.6 Ulcer Protective Drugs
4.2 By Type - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-Peptic Ulcer Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-Peptic Ulcer Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Peptic Ulcer Drugs Market Size, 2022 & 2029
5.1.2 Gastritis
5.1.3 Gastric Ulcers
5.1.4 Duodenal Ulcers
5.1.5 Gastroesophageal Reflux Disease (GERD)
5.2 By Application - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-Peptic Ulcer Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-Peptic Ulcer Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-Peptic Ulcer Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-Peptic Ulcer Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-Peptic Ulcer Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-Peptic Ulcer Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-Peptic Ulcer Drugs Revenue, 2018-2029
6.3.2 US Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.3.3 Canada Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.3.4 Mexico Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-Peptic Ulcer Drugs Revenue, 2018-2029
6.4.2 Germany Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.3 France Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.4 U.K. Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.5 Italy Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.6 Russia Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.4.8 Benelux Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-Peptic Ulcer Drugs Revenue, 2018-2029
6.5.2 China Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.5.3 Japan Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.5.4 South Korea Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.5.6 India Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-Peptic Ulcer Drugs Revenue, 2018-2029
6.6.2 Brazil Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.6.3 Argentina Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, 2018-2029
6.7.2 Turkey Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.7.3 Israel Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-Peptic Ulcer Drugs Market Size, 2018-2029
6.7.5 UAE Anti-Peptic Ulcer Drugs Market Size, 2018-2029
7 Anti-Peptic Ulcer Drugs Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Major Product Offerings
7.1.4 AstraZeneca Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Ask-pharm
7.2.1 Ask-pharm Company Summary
7.2.2 Ask-pharm Business Overview
7.2.3 Ask-pharm Anti-Peptic Ulcer Drugs Major Product Offerings
7.2.4 Ask-pharm Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.2.5 Ask-pharm Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Anti-Peptic Ulcer Drugs Major Product Offerings
7.3.4 Takeda Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Yangtze River Pharm
7.4.1 Yangtze River Pharm Company Summary
7.4.2 Yangtze River Pharm Business Overview
7.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Major Product Offerings
7.4.4 Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.4.5 Yangtze River Pharm Key News & Latest Developments
7.5 Shandong Luoxin
7.5.1 Shandong Luoxin Company Summary
7.5.2 Shandong Luoxin Business Overview
7.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Major Product Offerings
7.5.4 Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.5.5 Shandong Luoxin Key News & Latest Developments
7.6 Huadong Medicine
7.6.1 Huadong Medicine Company Summary
7.6.2 Huadong Medicine Business Overview
7.6.3 Huadong Medicine Anti-Peptic Ulcer Drugs Major Product Offerings
7.6.4 Huadong Medicine Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.6.5 Huadong Medicine Key News & Latest Developments
7.7 Changzhou Siyao
7.7.1 Changzhou Siyao Company Summary
7.7.2 Changzhou Siyao Business Overview
7.7.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Major Product Offerings
7.7.4 Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.7.5 Changzhou Siyao Key News & Latest Developments
7.8 Beijing Yuekang
7.8.1 Beijing Yuekang Company Summary
7.8.2 Beijing Yuekang Business Overview
7.8.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Major Product Offerings
7.8.4 Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.8.5 Beijing Yuekang Key News & Latest Developments
7.9 Guangdong Dahua
7.9.1 Guangdong Dahua Company Summary
7.9.2 Guangdong Dahua Business Overview
7.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Major Product Offerings
7.9.4 Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.9.5 Guangdong Dahua Key News & Latest Developments
7.10 Xian Janssen
7.10.1 Xian Janssen Company Summary
7.10.2 Xian Janssen Business Overview
7.10.3 Xian Janssen Anti-Peptic Ulcer Drugs Major Product Offerings
7.10.4 Xian Janssen Anti-Peptic Ulcer Drugs Revenue in Global Market (2018-2023)
7.10.5 Xian Janssen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Peptic Ulcer Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-Peptic Ulcer Drugs Market Drivers in Global Market
Table 3. Anti-Peptic Ulcer Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-Peptic Ulcer Drugs in Global Market
Table 5. Top Anti-Peptic Ulcer Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-Peptic Ulcer Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-Peptic Ulcer Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-Peptic Ulcer Drugs Product Type
Table 9. List of Global Tier 1 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Peptic Ulcer Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-Peptic Ulcer Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-Peptic Ulcer Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2024-2029
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Anti-Peptic Ulcer Drugs Product Offerings
Table 32. AstraZeneca Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. Ask-pharm Company Summary
Table 35. Ask-pharm Anti-Peptic Ulcer Drugs Product Offerings
Table 36. Ask-pharm Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Ask-pharm Key News & Latest Developments
Table 38. Takeda Company Summary
Table 39. Takeda Anti-Peptic Ulcer Drugs Product Offerings
Table 40. Takeda Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Takeda Key News & Latest Developments
Table 42. Yangtze River Pharm Company Summary
Table 43. Yangtze River Pharm Anti-Peptic Ulcer Drugs Product Offerings
Table 44. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Yangtze River Pharm Key News & Latest Developments
Table 46. Shandong Luoxin Company Summary
Table 47. Shandong Luoxin Anti-Peptic Ulcer Drugs Product Offerings
Table 48. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Shandong Luoxin Key News & Latest Developments
Table 50. Huadong Medicine Company Summary
Table 51. Huadong Medicine Anti-Peptic Ulcer Drugs Product Offerings
Table 52. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Huadong Medicine Key News & Latest Developments
Table 54. Changzhou Siyao Company Summary
Table 55. Changzhou Siyao Anti-Peptic Ulcer Drugs Product Offerings
Table 56. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Changzhou Siyao Key News & Latest Developments
Table 58. Beijing Yuekang Company Summary
Table 59. Beijing Yuekang Anti-Peptic Ulcer Drugs Product Offerings
Table 60. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Beijing Yuekang Key News & Latest Developments
Table 62. Guangdong Dahua Company Summary
Table 63. Guangdong Dahua Anti-Peptic Ulcer Drugs Product Offerings
Table 64. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Guangdong Dahua Key News & Latest Developments
Table 66. Xian Janssen Company Summary
Table 67. Xian Janssen Anti-Peptic Ulcer Drugs Product Offerings
Table 68. Xian Janssen Anti-Peptic Ulcer Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Xian Janssen Key News & Latest Developments
List of Figures
Figure 1. Anti-Peptic Ulcer Drugs Segment by Type in 2022
Figure 2. Anti-Peptic Ulcer Drugs Segment by Application in 2022
Figure 3. Global Anti-Peptic Ulcer Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Peptic Ulcer Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Peptic Ulcer Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Peptic Ulcer Drugs Revenue in 2022
Figure 8. By Type - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 16. US Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 28. China Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-Peptic Ulcer Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-Peptic Ulcer Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. AstraZeneca Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ask-pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Takeda Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Yangtze River Pharm Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Shandong Luoxin Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Huadong Medicine Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Changzhou Siyao Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Beijing Yuekang Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Guangdong Dahua Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Xian Janssen Anti-Peptic Ulcer Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
